Strauss SJ - Search Results

1

Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma.

Windsor R, Hamilton A, McTiernan A, Dileo P, Michelagnoli M, Seddon B, Strauss SJ, Whelan J. Windsor R, et al. Among authors: strauss sj. Eur J Cancer. 2022 Jul;170:131-139. doi: 10.1016/j.ejca.2022.04.007. Epub 2022 May 26. Eur J Cancer. 2022. PMID: 35635934

2

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

3

Late relapse of osteosarcoma: implications for follow-up and screening.

Strauss SJ, McTiernan A, Whelan JS. Strauss SJ, et al. Pediatr Blood Cancer. 2004 Nov;43(6):692-7. doi: 10.1002/pbc.20154. Pediatr Blood Cancer. 2004. PMID: 15390283

4

Experimental therapies in Ewing's sarcoma.

Windsor R, Strauss S, Seddon B, Whelan J. Windsor R, et al. Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784. Expert Opin Investig Drugs. 2009. PMID: 19236262 Review.

5

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Turner NC, Strauss SJ, Sarker D, Gillmore R, Kirkwood A, Hackshaw A, Papadopoulou A, Bell J, Kayani I, Toumpanakis C, Grillo F, Mayer A, Hochhauser D, Begent RH, Caplin ME, Meyer T. Turner NC, et al. Among authors: strauss sj. Br J Cancer. 2010 Mar 30;102(7):1106-12. doi: 10.1038/sj.bjc.6605618. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234360 Free PMC article. Clinical Trial.

6

Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Strauss SJ, Ng T, Mendoza-Naranjo A, Whelan J, Sorensen PH. Strauss SJ, et al. Oncologist. 2010;15(6):627-35. doi: 10.1634/theoncologist.2010-0093. Epub 2010 May 17. Oncologist. 2010. PMID: 20479280 Free PMC article. Review.

7

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.

Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS. Windsor RE, et al. Among authors: strauss sj. Cancer. 2012 Apr 1;118(7):1856-67. doi: 10.1002/cncr.26472. Epub 2011 Sep 1. Cancer. 2012. PMID: 21887680 Free article.

8

Incidence and survival of malignant bone sarcomas in England 1979-2007.

Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, Strauss SJ. Whelan J, et al. Among authors: strauss sj. Int J Cancer. 2012 Aug 15;131(4):E508-17. doi: 10.1002/ijc.26426. Epub 2011 Nov 2. Int J Cancer. 2012. PMID: 21913189 Free article.

9

ERBB4 confers metastatic capacity in Ewing sarcoma.

Mendoza-Naranjo A, El-Naggar A, Wai DH, Mistry P, Lazic N, Ayala FR, da Cunha IW, Rodriguez-Viciana P, Cheng H, Tavares Guerreiro Fregnani JH, Reynolds P, Arceci RJ, Nicholson A, Triche TJ, Soares FA, Flanagan AM, Wang YZ, Strauss SJ, Sorensen PH. Mendoza-Naranjo A, et al. Among authors: strauss sj. EMBO Mol Med. 2013 Jul;5(7):1087-102. doi: 10.1002/emmm.201202343. Epub 2013 May 16. EMBO Mol Med. 2013. PMID: 23681745 Free PMC article.

10

Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Frezza AM, Beale T, Bomanji J, Jay A, Kalavrezos N, Dileo P, Whelan J, Strauss SJ. Frezza AM, et al. Among authors: strauss sj. BMC Cancer. 2014 Jan 15;14:23. doi: 10.1186/1471-2407-14-23. BMC Cancer. 2014. PMID: 24422949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page